Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: How reliable are the results?

Anticancer Research

Volumn 27, Issue 5 B, 2007, Pages 3571-3575

  Baghi, Mehran ^a   Mack, Martin G ^a   Wagenblast, Jens ^a   Hambek, Markus ^a   Rieger, Jörg ^a   Bisdas, Sotirios ^a   Gstoettner, Wolfgang ^a   Engels, Knut ^a   Vogl, Thomas ^a   Knecht, Rainald ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Enhanced MRI; Head and neck cancer; Lymph node; Metastasis; Ultrasmall paramagnetic iron oxide; USPIO

Indexed keywords

IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FERRIC COMPOUNDS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING;

EID: 35349013606     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sakai O, Curtin HD, Romo LV and Som PM: Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease. Radiol Clin North Am 38: 979-998, 2000.
2. Mack MG, Balzer JO, Straub R, Eichler K and Vogl TJ: Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222: 239-244, 2002.
3. Baghi M, Mack MG, Hambek M, Rieger J, Vogl T, Gstoettner W and Knecht R: The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers. Anticancer Res 25: 3665-3670, 2005.
4. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM and Tempany CM: Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228: 777-788, 2003.
5. Patel SG and Shah JP: TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55: 242-258; quiz 261-242, 264, 2005.
6. van den Brekel MW, Castelijns JA and Snow GB: The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol 19: 695-700, 1998.
7. van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA and Snow GB: The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106: 987-991, 1996.
8. van den Brekel MW: Lymph node metastases: CT and MRI. Eur J Radiol 33: 230-238, 2000.
9. Friedman M, Roberts N, Kirshenbaum GL and Colombo J: Nodal size of metastatic squamous cell carcinoma of the neck. Laryngoscope 103: 854-856, 1993.
10. Som PM: Lymph nodes of the neck. Radiology 165: 593-600, 1987.
11. Dillon WP: Cervical nodal metastases: another look at size criteria. AJNR Am J Neuroradiol 19: 796-797, 1998.
12. Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y, Yuh WT, Runge VM, Morris MR, McLachlan SJ and Lufkin RB: Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192: 709-715, 1994.
13. Bellin MF, Roy C, Kinkel K, Thoumas D, Zaim S, Vanel D, Tuchmann C, Richard F, Jacqmin D, Delcourt A, Challier E, Lebret T and Cluzel P: Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles, initial clinical experience. Radiology 207: 799-808, 1998.
14. Harisinghani MG, Saini S, Slater GJ, Schnall MD and Rifkin MD: MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 7: 161-163, 1997.
15. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ and Mueller PR: MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologie correlation. AJR Am J Roentgenol 172: 1347-1351, 1999.
16. Hoffman HT, Quets J, Toshiaki T, Funk GF, McCulloch TM, Graham SM, Robinson RA, Schuster ME and Yuh WT: Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy. Laryngoscope 110: 1425-1430, 2000.
17. Nguyen BC, Stanford W, Thompson BH, Rossi NP, Kernstine KH, Kern JA, Robinson RA, Amorosa JK, Mammone JF and Outwater EK: Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J Magn Reson Imaging 10: 468-473, 1999.
18. Pannu HK, Wang KP, Borman TL and Bluemke DA: MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging 12: 899-904, 2000.
19. Cuccia G, Shelley OP, d'Alcontres FS, Giannitrapani M, Soutar DS and Camilleri IG: Evidence of significant sternocleidomastoid atrophy following modified radical neck dissection type III. Plast Reconstr Surg 117: 227-232, 2006.
20. Cappiello J, Piazza C, Giudice M, De Maria G and Nicolai P: Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope 115: 259-263, 2005.
21. Zhang B, Xu ZG and Tang PZ: Elective lateral neck dissection for laryngeal cancer in the clinically negative neck. J Surg Oncol 93: 464-467, 2006.